EBITDA

Halia Therapeutics is betting on a novel target to fight chronic inflammation. At a key summit, it will pitch its unique approach for cancer, obesity, and Alzheimer's.

A major contract with HawkEye 360 signals Europe's urgent push for sovereign defense, using commercial satellites to monitor invisible threats from space.

The biopharma company's strategic bid for non-dilutive funding could advance a first-in-class therapy for severe, untreated skin conditions.

Virtus Investment Partners' deal for Keystone National Group signals a major push to bring asset-backed lending to the mainstream wealth channel.

A new study reveals a massive shift in perception, with pro gaming now a top career choice for Gen Z, backed by a multi-billion dollar industry.

As ladder incidents cost the U.S. $24 billion annually, WERNER and ALI expand their decade-long safety campaign with new digital tools and training.

With its stock near a 52-week low after a Q4 earnings miss, ACV's upcoming presentation is a critical test of its tech-driven growth strategy.

French giant Efor deepens its North American footprint, acquiring CQV specialist DynamixE to target the complex cell and gene therapy manufacturing market.

PenFed Foundation's latest accelerator cohort showcases veteran entrepreneurs tackling everything from national security to healthcare with military precision.

For the third consecutive time, Equisoft's AI-native system is named a 'Luminary,' highlighting a major tech shift for insurers in Latin America.

StepStone Real Estate secures top PERE awards for its global firm and a landmark European deal, validating its powerful GP-led secondaries strategy.

NBA legend Kevin Garnett partners with smart mobility brand NAVEE, signaling a major play to conquer the Americas' market beyond the daily commute.

NVIDIA invests billions in optics leader Coherent to secure the high-speed, US-made components needed to power the next generation of AI factories.

With a $41M boost from a16z, Ease Health is using AI to unify a fractured behavioral health system, promising relief for overwhelmed providers.

In a deal highlighting intense focus on supply chain resilience, J.F. Lehman acquires critical forgings provider Forged Solutions Group from Arlington Capital.

With 175 million lenses implanted, Alcon solidifies its market leadership. Discover the technology giving patients unprecedented freedom from glasses.

With a $6B M&A war chest and a new AI focus, Roper Technologies takes the stage at Morgan Stanley. Here’s what investors will be watching for.

UroGen's new bladder cancer drug sees rapid uptake post-reimbursement code, but a $153M loss and fresh debt highlight its high-stakes growth strategy.

SaaS growth expert Eric Shoemaker takes the helm at Keebo, aiming to scale its AI-powered platform amid soaring enterprise demand for cloud cost control.

In a strategic move, CCC Intelligent Solutions adds former Salesforce and Informatica exec John Schweitzer to its board, signaling a major push in AI and data.